Pharming Group Cash Flow Statement 2019-2024 | PHAR

Fifteen years of historical annual cash flow statements for Pharming Group (PHAR).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-12.01$14.99$23.08$44.09$52.28
$15.93$13.19$19.61$8.31$5.80
$-6.48$-4.18$0.06$37.08$20.18
$9.44$9.01$19.67$45.39$25.97
$-18.54$2.36$5.92$-7.04$-9.51
$-14.43$-15.02$-6.15$-4.93$3.44
$16.23$11.99$-5.19$7.02$9.72
$-0.22$0.27$0.47$1.04$-2.83
$-16.96$-0.39$-4.96$-3.92$0.81
$-17.30$22.46$37.84$83.63$74.48
$-1.44$-1.38$-10.74$-4.66$-2.65
$-0.03$-0.60$-5.98$-10.64$-22.79
$0$0$0$0$0
$-149.20$0$0$-0.33$-2.80
$0$7.30$-4.59$0$0
$-149.20$7.30$-4.59$-0.33$-2.80
$21.28$0$0$0$0
$-129.39$5.32$-21.31$-15.63$-28.24
$0$0$0$85.59$-35.17
$-5.13$-3.31$-3.22$-2.19$-2.20
$-5.13$-3.31$-3.22$83.41$-37.38
$0$0$4.72$2.79$3.11
$0$0$4.72$2.79$3.11
$0$0$0$0$0
$4.09$-1.67$-29.45$-25.51$-29.18
$-1.04$-4.98$-27.95$60.69$-63.44
$-145.60$15.42$-13.24$131$-15.69
$9.25$6.39$9.06$6.54$4.28
$0$0$0$0$0